Frailty, Cognitive Impairment, and Anticoagulation Among Older Adults with Nonvalvular Atrial Fibrillation
Journal of the American Geriatrics Society
Fecha de publicación: 11 August 2020
DOI: https://doi.org/10.1111/jgs.16756
Autores: Tanya Mailhot RN, PhDDavid D. McManus MD, ScMMolly E. Waring PhDDarleen Lessard MSRobert Goldberg PhDBenita A. Bamgbade PharmD, PhDJane S. Saczynski PhD
Background: Oral anticoagulation (OAC) is challenging in older patients with nonvalvular atrial fibrillation (NVAF) who are often frail and have cognitive impairment. We examined the characteristics of older NVAF patients associated with higher odds of physical and cognitive impairments. We also examined if these high‐risk patients have different OAC prescribing patterns and their satisfaction with treatment because it may impact optimal management of their NVAF.
